Document:

<PAGE>

                                                                   Exhibit 10.32

                         MANAGEMENT STABILITY AGREEMENT

      This Management Stability Agreement is dated November 6, 2002, between
Tesoro Petroleum Corporation, a Delaware corporation (the "Company"), and J.
William Haywood ("Employee").

                                    Recitals:

      WHEREAS, the Board of Directors of the Company has determined that it is
in the best interest of the Company to reduce uncertainty to certain key
employees of the Company in the event of certain fundamental events involving
the control or existence of the Company;

      WHEREAS, the Board of Directors of the Company has determined that an
agreement protecting certain interests of key employees of the Company in the
event of certain fundamental events involving the control or existence of the
Company is in the best interest of the Company because it will assist the
Company in attracting and retaining key employees such as this Employee; and

      WHEREAS, the Employee is relying on this Agreement and the obligations of
the Company hereunder in continuing to work for the Company.

      NOW, THEREFORE, THE PARTIES AGREE AS FOLLOWS:

      1. Termination Following Change of Control.

      Should Employee at any time within two years of a change of control cease
to be an employee of the Company (or its successor), by reason of (i)
involuntary termination by the Company (or its successor) other than for "cause"
(following a change of control), "cause" shall be limited to the conviction of
or a plea of nolo contendere to the charge of a felony (which, through lapse of
time or otherwise, is not subject to appeal), a material breach of fiduciary
duty to the Company through the misappropriation of Company funds or property)
or (ii) voluntary termination by Employee for "good reason upon change of
control" (as defined below), the Company (or its successor) shall pay to
Employee within ten days of such termination the following severance payments
and benefits:

            (a) A lump-sum payment equal to two times the base salary of the
            Employee at the then current rate; and

            (b) A lump-sum payment equal to (i) two times the sum of the target
            bonuses under all of the Company's incentive bonus plans applicable
            to the Employee for the year in which the termination occurs or the
            year in which the change of control occurred, whichever is greater,
            and (ii) if termination occurs in the fourth quarter of a calendar
            year, the sum of the target bonuses under all of the Company's
            incentive bonus plans applicable to Employee for the year in which
            the termination occurs prorated daily based on the number of days

                                                                          Page 1
<PAGE>

            from the beginning of the calendar year in which the termination
            occurs to and including the date of termination.

The Company (or its successor) shall also provide continuing coverage and
benefits comparable to all life, health and disability plans of the Company for
a period of 24 months from the date of termination and shall receive two years
additional service credit under the current non-qualified supplemental pension
plans, or successors thereto, of the Company applicable to the Employee on the
date of termination.

                  For purposes of this Agreement, a "change of control" shall be
            deemed to have occurred if (i) there shall be consummated (A) any
            consolidation or merger of the Company in which the Company is not
            the continuing or surviving corporation or pursuant to which shares
            of the Company's Common Stock would be converted into cash,
            securities or other property, other than a merger of the Company
            where a majority of the Board of Directors of the surviving
            corporation are, and for a two year period after the merger continue
            to be, persons who were directors of the Company immediately prior
            to the merger or were elected as directors, or nominated for
            election as directors, by a vote of at least two-thirds of the
            directors then still in office who were directors of the Company
            immediately prior to the merger, or (B) any sale, lease, exchange or
            transfer (in one transaction or a series of related transactions) of
            all or substantially all of the assets of the Company, or (ii) the
            shareholders of the Company shall approve any plan or proposal for
            the liquidation or dissolution of the Company, or (iii) (A) any
            "person" (as such term is used in Sections 13(d) and 14(d)(2) of the
            Securities Exchange Act of 1934, as amended (the "Exchange Act"),
            other than the Company or a subsidiary thereof or any employee
            benefit plan sponsored by the Company or a subsidiary thereof, shall
            become the beneficial owner (within the meaning of Rule 13d-3 under
            the Exchange Act) of securities of the Company representing 20
            percent or more of the combined voting power of the Company's then
            outstanding securities ordinarily (and apart from rights accruing in
            special circumstances) having the right to vote in the election of
            directors, as a result of a tender or exchange offer, open market
            purchases, privately negotiated purchases or otherwise, and (B) at
            any time during a period of one year thereafter, individuals who
            immediately prior to the beginning of such period constituted the
            Board of Directors of the Company shall cease for any reason to
            constitute at least a majority thereof, unless the election or the
            nomination by the Board of Directors for election by the Company's
            shareholders of each new director during such period was approved by
            a vote of at least two-thirds of the directors then still in office
            who were directors at the beginning of such period.

                                                                          Page 2
<PAGE>

            For purposes of this Section 1, "good reason upon change of control"
            shall exist if any of the following occurs:

            (i) without Employee's express written consent, the assignment to
            Employee of any duties inconsistent with the employment of Employee
            immediately prior to the change of control, or a significant
            diminution of Employee's positions, duties, responsibilities and
            status with the Company from those immediately prior to a change of
            control or a diminution in Employee's titles or offices as in effect
            immediately prior to a change of control, or any removal of Employee
            from, or any failure to reelect Employee to, any of such positions;

            (ii) a reduction by the Company in Employee's base salary in effect
            immediately prior to a change of control;

            (iii) the failure by the Company to continue in effect any thrift,
            stock ownership, pension, life insurance, health, dental and
            accident or disability plan in which Employee is participating or is
            eligible to participate at the time of the change of control (or
            plans providing Employee with substantially similar benefits),
            except as otherwise required by the terms of such plans as in effect
            at the time of any change of control or the taking of any action by
            the Company which would adversely affect Employee's participation in
            or materially reduce Employee's benefits under any of such plans or
            deprive Employee of any material fringe benefits enjoyed by Employee
            at the time of the change of control or the failure by the Company
            to provide the Employee with the number of paid vacation days to
            which Employee is entitled in accordance with the vacation policies
            of the Company in effect at the time of a change of control;

            (iv) the failure by the Company to continue in effect any incentive
            plan or arrangement (including without limitation, the Company's
            Incentive Compensation Plan and similar incentive compensation
            benefits) in which Employee is participating at the time of a change
            of control (or to substitute and continue other plans or
            arrangements providing the Employee with substantially similar
            benefits), except as otherwise required by the terms of such plans
            as in effect at the time of any change of control;

            (v) the failure by the Company to continue in effect any plan or
            arrangement with respect to securities of the Company (including,
            without limitation, any plan or arrangement to receive and exercise
            stock options, stock appreciation rights, restricted stock or grants
            thereof or to acquire stock or other securities of the Company) in
            which Employee is participating at the time of a change of control
            (or to substitute and continue plans or arrangements providing the

                                                                          Page 3
<PAGE>

            Employee with substantially similar benefits), except as otherwise
            required by the terms of such plans as in effect at the time of any
            change of control or the taking of any action by the Company which
            would adversely affect Employee's participation in or materially
            reduce Employee's benefits under any such plan;

            (vi) the relocation of the Company's offices where Employee is
            presently based to a location outside that office area, or the
            Company's requiring Employee to be based anywhere other than at the
            location of the Company's offices where Employee is presently based,
            except for required travel on the Company's business to an extent
            substantially consistent with Employee's present business travel
            obligations, or, in the event Employee consents to any such
            relocation of the Company's offices where Employee is presently
            based, the failure by the Company to pay (or reimburse Employee for)
            all reasonable moving expenses incurred by Employee relating to a
            change of Employee's principal residence in connection with such
            relocation and to indemnify Employee against any loss (defined as
            the difference between the actual sale price of such residence and
            the higher of (a) Employee's aggregate investment in such residence
            or (b) the fair market value thereof as determined by a real estate
            appraiser reasonably satisfactory to both Employee and the Company
            at the time the Employee's principal residence is offered for sale
            in connection with any such change of residence;

            (vii) any failure by the Company to obtain the assumption of this
            Agreement by any successor or assign of the Company;

      In the event of a change of control as "change of control" is defined in
any stock option plan or stock option agreement pursuant to which the Employee
holds options to purchase common stock of the Company, Employee shall retain the
rights to all accelerated vesting and other benefits under the terms thereof.

      The Company shall pay any attorney fees incurred by Employee in reasonably
seeking to enforce the terms of this Paragraph 1.

      2. Complete Agreement.

      This Agreement constitutes the entire agreement between the parties and
cancels and supersedes all other agreements between the parties which may have
related to the subject matter contained in this Agreement.

      3. Modification; Amendment; Waiver.

      No modification, amendment or waiver of any provisions of this Agreement
shall be effective unless approved in writing by both parties. The failure at
any time to enforce any of the provisions

                                                                          Page 4
<PAGE>
of this Agreement shall in no way be construed as a waiver of such provisions
and shall not affect the right of either party thereafter to enforce each and
every provision hereof in accordance with its terms.

      4. Governing Law; Jurisdiction.

      This Agreement and performance under it, and all proceedings that may
ensue from its breach, shall be construed in accordance with and under the laws
of the State of Texas.

      5. Severability.

      Whenever possible, each provision of this Agreement shall be interpreted
in such manner as to be effective and valid under applicable law, but if any
provision of this Agreement shall be held to be prohibited by or invalid under
applicable law, such provision shall be ineffective only to the extent of such
prohibition or invalidity, without invalidating the remainder of such provision
or the remaining provisions of this Agreement.

      6. Assignment.

      The rights and obligations of the parties under this Agreement shall be
binding upon and inure to the benefit of their respective successors, assigns,
executors, administrators and heirs, provided, however, that the Company may not
assign any duties under this Agreement without the prior written consent of the
Employee.

      7. Limitation.

      This Agreement shall not confer any right or impose any obligation on the
Company to continue the employment of Employee in any capacity, or limit the
right of the Company or Employee to terminate Employee's employment.

      8. Notices.

      All notices and other communications under this Agreement shall be in
writing and shall be given in person or by telegraph, facsimile or first class
mail, certified or registered with return receipt requested, and shall be deemed
to have been duly given when delivered personally or three days after mailing or
one day after transmission of a telegram or facsimile, as the case may be, to
the representative persons named below:

      If to the Company:                 Corporate Secretary
                                         Tesoro Petroleum Corporation
                                         300 Concord Plaza Drive
                                         San Antonio, Texas 78216-6999

      If to the Employee:                J. William Haywood
                                         86 Sanders Ranch
                                         Moraga, California  94556

                                                                          Page 5
<PAGE>

      IN WITNESS WHEREOF, the parties have executed this Agreement as of the day
and year first above written.

                       COMPANY:            TESORO PETROLEUM CORPORATION

                                           By /s/ BRUCE A. SMITH
                                           -------------------------------------
                                           Bruce A. Smith
                                           Chairman  of the Board of  Directors,
                                           President and Chief Executive Officer

                       EMPLOYEE:           /s/ J. WILLIAM HAYWOOD
                                           -------------------------------------
                                           J. William Haywood

                                                                          Page 6Plan for Deferred Payment of Directors' Compensation

Exhibit 10.12 
 
 
MERCK & CO., INC. 
 
PLAN FOR DEFERRED PAYMENT OF 
 
DIRECTORS’ COMPENSATION 
 
(Amended and Restated January 10, 2003) 
 
 

 

 
TABLE OF
CONTENTS 
 

	 	  	 	  	 Page

	
	 Article I
	  	 Purpose
	  	 1

	
	 Article II
	  	 Election of Deferral, Measurement Methods and Distribution Schedule
	  	 1

	
	 Article III
	  	 Valuation of Deferred Amounts
	  	 2

	
	 Article IV
	  	 Redesignation Within a Deferral Account
	  	 3

	
	 Article V
	  	 Payment of Deferred Amounts
	  	 4

	
	 Article VI
	  	 Designation of Beneficiary
	  	 5

	
	 Article VII
	  	 Plan Amendment or Termination
	  	 5

	
	 Schedule A
	  	 Measurement Methods
	  	 6

 
 
 

(i) 

 
MERCK &
CO., INC. 
PLAN FOR DEFERRED PAYMENT OF 
DIRECTORS’ COMPENSATION 
 

	I.	 	PURPOSE 

 
To provide an arrangement under which directors of Merck & Co., Inc. other than current employees may (i) elect to voluntarily defer
payment of the annual retainer and meeting and committee fees until after termination of their service as a director, and (ii) value compensation mandatorily deferred on their behalf. 
 
 

	II.	 	ELECTION OF DEFERRAL, MEASUREMENT METHODS AND DISTRIBUTION SCHEDULE 

 

	 	A.	 	Election of Voluntary Deferral Amount 

 

	 	1.	 	Prior to December 28 of each year, each director is entitled to make an irrevocable election to defer until termination of service as a director receipt of payment
of (a) 50% or 100% of the retainer for the 12 months beginning April 1 of the next calendar year, (b) 50% or 100% of the Committee Chairperson retainer beginning April 1 of the next calendar year, and (c) 50% or 100% of the meeting and
committee fees for the 12 months beginning April 1 of the next calendar year. 

 

	 	2.	 	Prior to commencement of duties as a director, a director newly elected or appointed to the Board during a calendar year must make the election under this paragraph
for the portion of the Voluntary Deferral Amount applicable to such director’s first year of service (or part thereof). 

 

	 	3.	 	The Voluntary Deferral Amount shall be credited as follows: (1) Meeting and committee fees that are deferred are credited as of the day the director’s services
are rendered; (2) if the Board retainer and/or Committee Chairperson retainer is deferred, a pro-rata share of the deferred retainer is credited on the last business day of each calendar quarter. The dates the Voluntary Deferral Amount, or parts
thereof, are credited to the director’s deferred account are hereinafter referred to as the Voluntary Deferral Dates. 

 

	 	B.	 	Mandatory Deferral Amount 

 

	 	1.	 	On the Friday following the Company’s Annual Meeting of Stockholders (such Friday hereinafter referred to as the “Mandatory Deferral Date”), each
director will be credited with an amount equivalent to one-third of the annual cash retainer for the 12 month period beginning on the April 1 preceding the Annual Meeting (the “Mandatory Deferral Amount”). The Mandatory Deferral Amount
will be measured by the Merck Common Stock account. 

 

	 	2.	 	A director newly elected or appointed to the Board after the Mandatory Deferral Date will be credited with a pro rata portion of the Mandatory Deferral Amount
applicable to such director’s first year of service (or part thereof). Such pro rata portion shall be credited to the director’s account on the first day of such director’s service. 

 

1 

 

	 	C.	 	Election of Measurement Method 

 

	 	  	 	Each such annual election referred to in Section A shall include an election as to the measurement method or methods by which the value of amounts deferred will be
measured in accordance with Article III, below. The available measurement methods are set forth on Schedule A hereto. 

 

	 	D.	 	Election of Distribution Schedule 

 

	 	  	 	Each annual election referred to in Section A above shall also include an election to receive payment following termination of service as a director of all Voluntary
Deferral Amounts and Mandatory Deferral Amounts in a lump sum either immediately or one year after such termination, or in quarterly or annual installments over five, ten or fifteen years. 

 
 

	III.	 	VALUATION OF DEFERRED AMOUNTS 

 

	 	A.	 	Common Stock 

 

	 	1.	 	Initial Crediting.    The annual Mandatory Deferral Amount shall be used to determine the number of full and partial shares of Merck
Common Stock which such amount would purchase at the closing price of the Common Stock on the New York Stock Exchange on the Mandatory Deferral Date. 

 

	 	  	 	That portion of the Voluntary Deferral Amount allocated to Merck Common Stock shall be used to determine the number of full and partial shares of Merck Common Stock
which such amount would purchase at the closing price of the Common Stock on the New York Stock Exchange on the applicable Voluntary Deferral Date. 

 

	 	  	 	However, should it be determined by the Committee on Directors of the Board of Directors that a measurement of Merck Common Stock on any Mandatory or Voluntary
Deferral Date would not constitute fair market value, then the Committee shall decide on which date fair market value shall be determined using the valuation method set forth in this Article III, Section A.1. 

 

	 	  	 	At no time during the deferral period will any shares of Merck Common Stock be purchased or earmarked for such deferred amounts nor will any rights of a shareholder
exist with respect to such amounts. 

 

	 	2.	 	Dividends.    Each director’s account will be credited with the additional number of full and partial shares of Merck Common Stock
which would have been purchasable with the dividends on shares previously credited to the account at the closing price of the Common Stock on the New York Stock Exchange on the date each dividend was paid. 

 

	 	3.	 	Distributions.    Distribution from the Merck Common Stock account will be valued at the closing price of Merck Common Stock on the New
York Stock Exchange on the distribution date. 

 

2 

 

	 	B.	 	Mutual Funds 

 

	 	1.	 	Initial Crediting.    The amount allocated to each Mutual Fund shall be used to determine the full and partial Mutual Fund shares which
such amount would purchase at the closing net asset value of the Mutual Fund shares on the Mandatory or Voluntary Deferral Date, whichever is applicable. The director’s account will be credited with the number of full and partial Mutual Fund
shares so determined. 

 

	 	  	 	At no time during the deferral period will any Mutual Fund shares be purchased or earmarked for such deferred amounts nor will any rights of a shareholder exist with
respect to such amounts. 

 

	 	2.	 	Dividends.    Each director’s account will be credited with the additional number of full and partial Mutual Fund shares which would
have been purchasable, at the closing net asset value of the Mutual Fund shares as of the date each dividend is paid on the Mutual Fund shares, with the dividends which would have been paid on the number of shares previously credited to such account
(including pro rata dividends on any partial shares). 

 

	 	3.	 	Distributions.    Mutual Fund distributions will be valued based on the closing net asset value of the Mutual Fund shares on the
distribution date. 

 

	 	C.	 	Adjustments 

 

	 	  	 	In the event of a reorganization, recapitalization, stock split, stock dividend, combination of shares, merger, consolidation, rights offering or any other change in
the corporate structure or shares of the Company or a Mutual Fund, the number and kind of shares or units of such investment measurement method available under this Plan and credited to each director’s account shall be adjusted accordingly.

 
 

	IV.	 	REDESIGNATION WITHIN A DEFERRAL ACCOUNT 

 

	 	A.	 	General 

 

	 	  	 	A director may request a change in the measurement methods used to value all or a portion his/her account other than Merck Common Stock. Amounts deferred using
the Merck Common Stock method and any earnings attributable to such deferrals may not be redesignated. The change will be effective on (i) the day when the redesignation request is received pursuant to administrative guidelines established by
the Human Resources Financial Services area of the Treasury department, provided the request is received prior to the close of the New York Stock Exchange on such day or (ii) the next following business day if the request is received when the New
York Stock Exchange is closed. 

 

	 	B.	 	When Redesignation May Occur 

 

	 	1.	 	During Active Service.    There is no limit on the number of times a director may redesignate the portion of his/her deferred account
permitted to be redesignated. Each such request shall be irrevocable and can be designated in whole percentages or as a dollar amount. 

 

3 

 

	 	2.	 	After Death.    Following the death of a director, the legal representative or beneficiary of such director may redesignate subject to the
same rules as for active directors set forth in Article IV, Section B.1. 

 

	 	C.	 	Valuation of Amounts to be Redesignated  

 

	 	  	 	The portion of the director’s account to be redesignated will be valued at its cash equivalent and such cash equivalent will be converted into shares or units
of the other measurement method(s). For purposes of such redesignations, the cash equivalent of the value of the Mutual Fund shares shall be the closing net asset value of such Mutual Fund on (i) the day when the redesignation request is received
pursuant to administrative guidelines established by the Human Resources Financial Services area of the Treasury department, provided the request is received prior to the close of the New York Stock Exchange on such day or (ii) the next following
business day if the request is received when the New York Stock Exchange is closed. 

 
 

	V.	 	PAYMENT OF DEFERRED AMOUNTS 

 

	 	A.	 	Payment 

 

	 	  	 	All payments to directors of amounts deferred will be in cash in accordance with the distribution schedule elected by the director pursuant to Article II, Section D.
Distributions shall be pro rata by measurement method. Distributions shall be valued on the fifteenth day of the distribution month (or, if such day is not a business day, the next business day) and paid as soon thereafter as possible.

 

	 	B.	 	Changes to Distribution Schedule Prior to Termination 

 

	 	  	 	Upon the request of a director made at any time during the calendar year immediately preceding the calendar year in which service as a director is expected to
terminate, the Committee on Directors of the Board of Directors (“Committee on Directors”), in its sole discretion, may authorize: (a) an extension of a payment period beyond that originally elected by the director not to exceed that
otherwise allowable under Article II, Section D, and/or (b) a payment frequency different from that originally elected by the director. Such request may not be made with regard to amounts deferred after December 31, 1990 using the Merck Common Stock
method and to any earnings attributable to such deferrals. Deferrals into Merck Common Stock made after December 31, 1990 and any earnings thereon may only be distributed in accordance with the schedule elected by the director under Article II,
Section D or determined by the Committee on Directors under Article VI. 

 

	 	C.	 	Post-Termination Changes to Distribution Schedule 

 

	 	  	 	Following termination of service as a director, each director may make one request for a further extension of the period for distribution of his/her deferred
compensation. Such request must be received by the Committee on Directors prior to the first distribution to the participant under his/her previously elected distribution schedule. Any revised distribution schedule may not exceed the deferral period
otherwise allowable under Article II, Section C. This request may be granted and a new payment schedule determined in the sole discretion of the Committee on Directors. 

 

4 

	 	  	 	Such request may not be made with regard to amounts deferred after December 31, 1990 using the Merck Common Stock Method and to any earnings attributable to such
deferrals. Any retired director who is not subject to U.S. income tax may petition the Committee on Directors to change payment frequency, including a lump sum distribution, and the Committee on Directors may grant such petition if, in its
discretion, it considers there to be reasonable justification therefor. Deferrals into Merck Common Stock made after December 30, 1990 and any earnings thereon may only be distributed in accordance with the schedule elected by the director under
Article II, Section D or determined by the Committee on Directors under Article VI. 

 

	 	D.	 	Forfeitures 

 

	 	  	 	A director’s deferred amount attributable to the Mandatory Deferral Amount and earnings thereon shall be forfeited upon his or her removal as a director or upon
a determination by the Committee on Directors in its sole discretion, that a director has: 

 

	 	(i)	 	joined the Board of, managed, operated, participated in a material way in, entered employment with, performed consulting (or any other) services for, or otherwise
been connected in any material manner with a company, corporation, enterprise, firm, limited partnership, partnership, person, sole proprietorship or any other business entity determined by the Committee on Directors in its sole discretion to be
competitive with the business of the Company, its subsidiaries or its affiliates (a “Competitor”); 

 

	 	(ii)	 	directly or indirectly acquired an equity interest of five (5) percent or greater in a Competitor; or 

 

	 	(iii)	 	disclosed any material trade secrets or other material confidential information, including customer lists, relating to the Company or to the business of the Company
to others, including a Competitor. 

 
 

	VI.  	 	DESIGNATION OF BENEFICIARY 

 

	 	  	 	In the event of the death of a director, the deferred amount at the date of death shall be paid to the last named beneficiary or beneficiaries designated by the
director, or, if no beneficiary has been designated, to the director’s legal representative, in one or more installments as the Committee on Directors in its sole discretion may determine. 

 
 

	VII.	 	PLAN AMENDMENT OR TERMINATION 

 

	 	  	 	The Committee on Directors shall have the right to amend or terminate this Plan at any time for any reason. 

 

5 

 
SCHEDULE A

 
MEASUREMENT METHODS 
 
(January 1, 2002 – January 10, 2003) 
 
Merck Common Stock 
 
Mutual Funds 
 
American Century Emerging Markets Fund 
American Century Europacific Growth Fund 
Fidelity Destiny I 
Fidelity Dividend Growth 
Fidelity Equity Income Fund 
Fidelity Low-Priced Stock Fund 
Fidelity Retirement Money Market 
Fidelity Spartan Government Income 
Fidelity Spartan U.S. Equity Index 
Franklin Small-Mid Cap Growth A 
Janus Enterprise 
Janus Growth & Income 
Liberty Acorn Z 
PIMCO Foreign Bond Institutional 
PIMCO Long Term US Government Institutional 
PIMCO Total Return Institutional 
Putnam Global Equity Fund A* 
Putnam International Voyager A 
Putnam Vista A 
T. Rowe Price Blue Chip Growth Fund 
Vanguard Asset Allocation 
 
*From September 20, 2002 — September 30, 2002, this investment was briefly named the Putnam Global Growth Fund A as a result of the merger, in September 2002, of Putnam Global Equity Fund A with Putnam Global Growth Fund A. The
merged fund briefly retained the name “Putnam Global Growth Fund A.” Effective October 1, 2002, the merged fund changed its name to “Putnam Global Equity Fund A.” 
 

6 

 
SCHEDULE A

 
MEASUREMENT METHODS 
 
(Effective January 11, 2003) 
 
Merck Common Stock 
 
Mutual Funds 
 
American Century Emerging Markets Institutional 
American Funds EuroPacific Growth Fund 
Fidelity Destiny I 
Fidelity Dividend Growth 
Fidelity Equity-Income 
Fidelity Low-Priced Stock 
Fidelity Retirement Money Market 
Fidelity Spartan Government Income 
Fidelity Spartan U.S. Equity Index 
Franklin Small-Mid Cap Growth A 
Janus Enterprise 
Janus Growth & Income 
Liberty Acorn Class Z 
PIMCO Foreign Bond Institutional 
PIMCO Long Term US Government Institutional 
PIMCO Total Return Institutional 
Putnam Global Equity A 
Putnam International Voyager A 
Putnam Vista A 
T. Rowe Price Blue Chip Growth 
Vanguard Asset Allocation 
 
 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00048-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00048-of-00352.parquet"}]]